Integra Lifesciences Holdings (IART) Long-Term Debt Repayments (2009 - 2016)

Integra Lifesciences Holdings has disclosed Long-Term Debt Repayments across 4 years of filings, most recently posting $166000.0 for Q4 2016.

• Long-Term Debt Repayments for Q4 2016 came in at $166000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2017 was $166000.0 (down 65.91% YoY), and the FY2025 annual result was $575.0 million, changed N/A from the prior year.
• Long-Term Debt Repayments came in at $166000.0 for Q4 2016 at Integra Lifesciences Holdings, up from $164000.0 in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $2.1 million in Q3 2015 to a low of -$370000.0 in Q4 2014.
• The 3-year median for Long-Term Debt Repayments is $163000.0 (2016), against an average of $288363.6.
• Across the five-year window, Long-Term Debt Repayments surged 1598.4% in 2015 and tumbled 92.28% in 2016, its largest moves.
• Integra Lifesciences Holdings' Long-Term Debt Repayments stood at -$370000.0 in 2014, then surged by 673.78% to $2.1 million in 2015, then slumped by 92.18% to $166000.0 in 2016.
• The last three Long-Term Debt Repayments figures came in at $166000.0 (Q4 2016), $164000.0 (Q3 2016), and $163000.0 (Q2 2016), per Business Quant data.